Previous Close | 58.01 |
Open | 59.00 |
Bid | 60.14 x 1800 |
Ask | 60.17 x 1300 |
Day's Range | 58.90 - 60.29 |
52 Week Range | 52.71 - 83.25 |
Volume | |
Avg. Volume | 11,536,189 |
Market Cap | 75.605B |
Beta (5Y Monthly) | 0.54 |
PE Ratio (TTM) | 15.25 |
EPS (TTM) | 3.94 |
Earnings Date | Feb 05, 2025 - Feb 10, 2025 |
Forward Dividend & Yield | 2.66 (4.59%) |
Ex-Dividend Date | Oct 21, 2024 |
1y Target Est | 68.35 |
Israel "Izzy" Englander's net worth tops $14 billion. The billionaire bought one high-yield dividend stock hand over fist in Q3. If you glance at Englander's purchases for Millennium Management in Q3, you'll probably notice he added significantly to several existing holdings.
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?